Speaker Profile

Ph.D., CTO, Genomill Health

Biography
Manu Tamminen is an expert in molecular biology, next- generation DNA sequencing and bioinformatics. He received his PhD from the University of Helsinki and did his post-doctoral research at MIT and ETH Zürich, where he developed methodologies for single cell sequencing and molecular counting. He is currently an Adjunct Professor and Senior Lecturer of Genetics at the University of Turku and has authored several high-impact research publications.


Clinical Dx Showcase:
Genomill Health

Genomill Health Inc is a precision diagnostics company with a mission to revolutionize liquid biopsies with their patent-pending Geno1 technology.

Geno1 Permits Highly Scalable Liquid Biopsies
Liquid biopsies are revolutionizing cancer diagnostics but currently suffer from high cost, limited scalability and long turn-around times. Geno1 is a minimalistic, ligation-based workflow which harnessed next-generation DNA sequencing to provide infinitely scalable molecular quantification for liquid biopsies and beyond.

 Session Abstract – PMWC 2022 Silicon Valley


The PMWC 2022 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.

- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Nerodegenerative